Skip to content

Guidelines and statements

guidelines and statements

These guidelines and statements reflect the evidence-based positions and practices of the world’s most highly respected diabetes associations.

Guidelines and statements

2023 American Association of Clinical Endocrinology consensus statement: Comprehensive T2D management algorithm

AACE 2023

IPSAD clinical practice consensus guidelines 2022

ISPAD 2022

2018 Diabetes Canada clinical practice guidelines – Diabetes and driving

Diabetes Canada 2018

Hypoglycaemia classification consensus statement

as published in Diabetes Care

as published in Diabetologia

IHSG 2017

Standards of medical care in diabetes

ADA 2023

Global guideline for type 2 diabetes

IDF 2017

Diabetes self-management education and support in adults with type 2 diabetes: A consensus report

ADA/ADCES/ Academy of Nutrition and Dietetics/AAFP/AAAP/AANP/AphA 2020

Management of hyperglycemia in type 2 diabetes


Diabetes and driving: position statement

ADA 2014

Hypoglycemia and diabetes

ADA/ES workgroup 2013

Hypoglycemia: clinical practice guideline

Diabetes Canada 2018

* AACE = American Association of Clinical Endocrinologists; AADE = American Association of Diabetes Educators; ACE = American College of Endocrinology; ADA = American Diabetes Association; AND = Academy of Nutrition and Dietetics; CDA = Canadian Diabetes Association; EASD = European Association for the Study of Diabetes; ES = Endocrine Society; IDF = International Diabetes Federation; IHSG = International Hypoglycaemia Study Group; ISPAD = International Society for Pediatric and Adolescent Diabetes